e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Multi-omic molecular profiling of lung cancer in COPD
Brian J. Sandri, Adam Kaplan, Shane W. Hodgson, Mark Peterson, Svetlana Avdulov, LeeAnn Higgins, Todd Markowski, Ping Yang, Andrew H. Limper, Timothy J. Griffin, Peter Bitterman, Eric F. Lock, Chris H. Wendt
Source:
Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Brian J. Sandri, Adam Kaplan, Shane W. Hodgson, Mark Peterson, Svetlana Avdulov, LeeAnn Higgins, Todd Markowski, Ping Yang, Andrew H. Limper, Timothy J. Griffin, Peter Bitterman, Eric F. Lock, Chris H. Wendt. Multi-omic molecular profiling of lung cancer in COPD. Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Analysis and comparison of the transcriptome of COPD patients with and without lung cancer
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007
Metabolomics in lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Epigenetics in IPF and lung cancer
Source: Research Seminar 2015
Year: 2015
DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Airway gene expression as a link between COPD and lung cancer
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009
Validation of diagnostic molecular markers in bronchial fluid for lung cancer
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Early detection of lung cancer in patients with COPD by eNose technology
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007
Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers
Source: Eur Respir J 2015; 45: 1403-1414
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept